If you liked this article you might like

Jim Cramer's 'Mad Money' Recap: These Are the Sectors to Buy Now
Impax (IPXL) Stock Plummets on Weak Q2 Results, Guidance
Changing Landscape for Generic-Drug Makers Creates Opportunities
Teva Inches Closer to Completion of Allergan Generics Deal